We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

(MIGA) Mini Geriatric Assessment To Replace the Comprehensive Geriatric Assessment (MIGA)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2011 by Tel-Aviv Sourasky Medical Center.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01318759
First Posted: March 18, 2011
Last Update Posted: March 18, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Tel-Aviv Sourasky Medical Center
  Purpose

This is a comprehensive Geriatric Assessment (CGA) currently used to evaluate elderly people in order to be able to assess their multiple organ pathology, cognitive, functional and social problems. This CGA is a very time consuming tool although a powerful one.

The investigators want to present a new assessment test witch is short and comprehensive tool witch will be checked in ambulatory and in-hospital geriatric patients.


Condition
Geriatric Disorder

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: (MIGA) Mini Geriatric Assessment as Compared to the Current CGA

Further study details as provided by Tel-Aviv Sourasky Medical Center:

Estimated Enrollment: 400
Study Start Date: March 2011
Estimated Study Completion Date: March 2014
Estimated Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)
Detailed Description:

MIGA test (Mini Geriatric Assessment) includes the following parameters Walking outdoors, Transfer, ADL-Dressing, Washing, Continence, Vision, Hearing, Pain, Sleeping, Weight loss, Get-Up-And-Go test, Short term memory, Clock drawing test, Falls, functional reach of hands, Depression, Behavioral problems, social support, Admissions, Polypharmacy,

All patients will be assessed by the traditional CGA and by the new MIGA test. Time consuming of the two tests will be measured and compared.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   65 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
people aged over 65
Criteria

Inclusion Criteria:

  • Elderly people age 65 and above,
  • In patients hospitalized in the geriatric department
  • Out patients -from the geriatric out patient clinic
  • Elderly patients visiting in the emergency room

Exclusion criteria:

  • People under 65 years old
  • Critically ill patients ( acute infection, acute myocardial infarction, hypoxia, hemodynamic instability)
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01318759


Locations
Israel
Geriatric department , Tel Aviv Sourasky Medical Center Recruiting
Tel Aviv, Israel, 64239
Contact: Oksana Borodin, MD    972-527-360460    oksana.borodin@gmail.com   
Contact: Yaffa Lerman, MD    972-3-6974074    Yaffale@tasmc.health.gov.il   
Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
Investigators
Study Director: Yaffa Lerman, MD Tel-Aviv Sourasky Medical Center
Principal Investigator: Oksana Borodin, MD Tel-Aviv Sourasky Medical Center
  More Information

Responsible Party: Yaffa Lerman MD, Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier: NCT01318759     History of Changes
Other Study ID Numbers: 0047-11-tav
First Submitted: March 17, 2011
First Posted: March 18, 2011
Last Update Posted: March 18, 2011
Last Verified: March 2011